Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail
-

Vaprisol (conivaptan hydrochloride) Injection
Company: Astellas Pharma US, Inc.
NDA: 022016
Approval Date: 2/28/2007

 

Date created: November 3, 2008

Back to Top    Drugs@FDA

 

Note: Documents in PDF format require the Adobe Acrobat Reader®.

-
-